Search Results 481-490 of 14809 for anti-TNF drugs

1. Mayo Clinic Comprehensive Cancer Center Research

   Research in the Experimental Therapeutics Program of Mayo Clinic Comprehensive Cancer Center focuses on signaling pathways, anti-cancer drugs, ...

2. An Investigational Study of Experimental Medication BMS-986165 in Participants With Moderate to Severe Crohn's Disease - Mayo Clinic

   This is an investigational study, also known as LATTICE-CD, of the experimental medication BMS-986165 in participants with moderate to severe Crohn's Disease, a ...

3. Xolair (Omalizumab) for Treatment of Drug-induced Acute Tubulointerstitial Nephritis (AIN) - Mayo Clinic

   About this study. The investigators goal is to evaluate the role of XOLAIR® in treatment of Acute Tubulointerstitial Nephritis (AIN) with the goal of ...

4. Lenvatinib (Oral Route) Description and Brand Names - Mayo Clinic

   Lenvatinib is also used in combination with pembrolizumab injection as first-line treatment of advanced renal cell carcinoma (RCC), a kind of kidney cancer, ...

5. Fluticasone (Nasal Route) Before Using - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

6. Pentostatin (Intravenous Route) Before Using - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

7. Epirubicin (Intravenous Route) Precautions - Mayo Clinic

   Male patients who have female partners should use effective birth control during treatment with this medicine and for at least 3 months after the last dose.

8. Fam-Trastuzumab Deruxtecan-Nxki (Intravenous Route) Description and Brand Names - Mayo Clinic

   ... anti-HER2 breast cancer treatment for metastatic disease or have breast cancer that has come back during or within 6 months of completing treatment for ...

9. A Study to Evaluate the Safety and Effectiveness of BMS-986165 in Subjects with Moderate-to-Severe Ulcerative Colitis (UC) - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic ... anti-tumor necrosis factor (TNF)-α agents, integrin inhibitor. Exclusion ...

10. Fosinopril And Hydrochlorothiazide (Oral Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...